Kiniksa Pharmaceuticals International, plc

KNSANASDAQHealthcareDrug Manufacturers - Specialty & Generic

$79.94- (-)1Y +105.40%

As of Oct 15, 2026 close

Market cap: $6.67B
P/E (TTM): 82.66
Forward P/E: 39.99
Dividend yield: -
52-week range: $35.20$82.94
Volume (live): -
Avg. volume (3M): 568.35K

Kiniksa Pharmaceuticals International, plc (KNSA) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Kiniksa Pharmaceuticals International, plc stock.

Analyst Consensus Rating

Investment consensus from 8 professional research analysts

Consensus Rating

Buy

Based on 8 unique analysts

(10 total ratings in last 90 days)

Medium Confidence∞:1 Buy/Sell

Average Price Target

$96.57

+20.80% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest KNSA Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Sep 30, 2026	Yanan Zhu	Wells Fargo	Maintains	Buy	$87.00
Sep 17, 2026	Zacks Equity Research	Zacks Equity Research	Initiates Coverage	Hold	-
Aug 13, 2026	Edward Nash	Canaccord Genuity	Reiterates	Buy	$98.00
Jul 30, 2026	Paul Choi	Goldman Sachs	Maintains	Buy	$75.00 → $90.00 +15.00 (+20.0%)
Jul 30, 2026	Zacks Equity Research	Zacks Equity Research	Initiates Coverage	Buy	-
Jul 29, 2026	David Nierengarten	Wedbush	Reiterates	Buy	$72.00 → $99.00 +27.00 (+37.5%)
Jul 29, 2026	Anupam Rama	JP Morgan	Reiterates	Buy	$72.00 → $107.00 +35.00 (+48.6%)
Jul 29, 2026	Geoff Meacham	Citi	Maintains	Buy	$60.00 → $100.00 +40.00 (+66.7%)
Jul 28, 2026	David Nierengarten	Wedbush	Reiterates	Buy	$72.00 → $99.00 +27.00 (+37.5%)
Jul 28, 2026	Nicholas Lorusso	TD Cowen	Maintains	Buy	$65.00 → $95.00 +30.00 (+46.1%)

Yanan Zhu

Wells Fargo

BuyMaintains

$87.00

Sep 30

Zacks Equity Research

HoldInitiates Coverage

Sep 17

Edward Nash

Canaccord Genuity

BuyReiterates

$98.00

Aug 13

Paul Choi

Goldman Sachs

BuyMaintains

$75.00 → $90.00

Jul 30

Zacks Equity Research

BuyInitiates Coverage

Jul 30

David Nierengarten

Wedbush

BuyReiterates

$72.00 → $99.00

Jul 29

Anupam Rama

JP Morgan

BuyReiterates

$72.00 → $107.00

Jul 29

Geoff Meacham

Citi

BuyMaintains

$60.00 → $100.00

Jul 29

David Nierengarten

Wedbush

BuyReiterates

$72.00 → $99.00

Jul 28

Nicholas Lorusso

TD Cowen

BuyMaintains

$65.00 → $95.00

Jul 28

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Sep 30, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for KNSA?

The analyst consensus rating for KNSA is Buy, based on the latest ratings from 8 analysts over the last 90 days.

What is the average price target for KNSA?

The average 12-month price target for KNSA is $96.57, representing an upside of 20.8% from the Oct 15, 2026 close of $79.94.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.